Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02532647 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
A Phase 3 study, sponsored by Paion UK.
- Completed
- Registry status
- Phase 3
- Development phase
- 79
- Enrollment target
NCT02532647 is a Phase 3 study that has completed, run by Paion UK. The registered enrollment target is 79 participants.
The verdict
NCT02532647, a Phase 3 study, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 79 participants
- Enrollment target
Study Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for midazolam, in American Society of Anesthesiologists (ASA) Grade III and IV patients (ASA status evaluated by an anesthesiologist not otherwise involved in the study) undergoing a colonoscopy for diagnostic or therapeutic reasons.
Interventions
- DRUG Placebo
- DRUG Midazolam
- DRUG Remimazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02532647
The ClinicalTrials.gov registry entry for NCT02532647 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02532647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02532647 about?
NCT02532647 is a clinical study titled "Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy". A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for midazolam, in American Society of Anesthesiologists (ASA) Grade III and IV patients (ASA status evaluated by an anesthesi...
What is the current status of trial NCT02532647?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 79 participants. The study started on 2015-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02532647?
The interventions under investigation include: Placebo (DRUG), Midazolam (DRUG), Remimazolam (DRUG).
Who is sponsoring clinical trial NCT02532647?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.